DC
PACB icon

Deere & Company’s Pacific Biosciences PACB Stock Holding History

Deere & Company’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,038
Closed -$394K – 1133
2015
Q4 		$394K Buy
+30,038
New +$269K 0.02% 654
2015
Q3 		– Sell
-48,265
Closed -$278K – 1016
2015
Q2 		$278K Buy
48,265
+16,853
+54% +$97.5K 0.01% 789
2015
Q1 		$183K Hold
31,412
– – 0.01% 920
2014
Q4 		$246K Sell
31,412
-13,394
-30% -$85.7K 0.01% 793
2014
Q3 		$220K Buy
+44,806
New +$234K 0.01% 836

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Deere & Company's PACB Position: Q1 2016 in Review

Deere & Company sold out of Pacific Biosciences (PACB) in Q1 2016, closing a stake of 30,038 shares — an estimated $394K sold.

Deere & Company first reported a position in PACB in Q3 2014 and held it in 5 quarters. The position peaked at $394K in Q4 2015. 129 funds tracked by Wall St. Rank hold PACB as of Q1 2016.

  • Deere & Company reported no remaining Pacific Biosciences position as of Q1 2016 after selling out during the quarter.
  • Deere & Company sold 30,038 Pacific Biosciences shares in Q1 2016, an estimated $394K.
  • Deere & Company first reported a position in Pacific Biosciences in Q3 2014 and held it in 5 quarters.
  • Deere & Company's Pacific Biosciences position peaked at $394K in Q4 2015.
  • 129 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2016.

Based on Deere & Company's 13F filing for Q1 2016, filed 9 May 2016.